US$ 25.80
action of glp 1 agonist GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes What is GLP-1 and Its
Description
GLP-1 is a hormone that the gut produces after eating to regulate blood sugar, slow digestion and manage hunger

or oral administration

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Purpose of Review This review provides a comprehensive and scholarly examination of glucagon-like peptide-1 receptor (GLP-1R) agonists, tracing their evolution from glycemic control agents in diabetes mellitus (DM) to multifaceted therapeutics with expanding indications in cardiovascular, renal, and metabolic health

Weight Support*

Read more